A new technology elucidated yesterday in the journal Nature has the potential to be a leap forward in DNA synthesis, allowing ...
The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...
Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...
New product delivers up to 7kb of high-accuracy DNA in as fast as 7 days, providing an unparalleled combination of speed, length, and quality to the synthetic biology market SAN CARLOS, ...
New collaboration empowers customers with sequence-perfect constructs as long as 50 kb Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...
Traditional chemical DNA synthesis rarely produces sequences beyond 10 kb, forcing researchers to assemble fragments manually — a process prone to errors and delays. Ansa’s enzymatic platform ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results